SAN FRANCISCO, CA / ACCESSWIRE / November 11, 2024 / Ambience Healthcare - the leading clinical AI platform for scribing, point-of-care CDI & coding, patient summaries, and referrals - today announced ...

Aptevo Therapeutics and Alligator Bioscience report favorable safety, tolerability and evidence of biological activity of ALG.APV-527, more than half of evaluable patients achieved stable diseaseColon ...

SAN DIEGO, CA / ACCESSWIRE / November 11, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump ...

STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today announces that it presented promising data from its ...

Theramex has announced that the Scottish Medicine Consortium (SMC) has recommended Yselty® for the treatment of moderate to severe symptoms of uterine fibroids (UFs) aligned to the product indication ...

The global hepatitis B diagnostic tests market is on the cusp of substantial expansion, driven by a combination of increasing disease incidence, heightened global awareness campaigns, and rapid ...

In accordance with the resolution of the Annual General Meeting on May 14th, 2024, the Chairman of the Board has contacted the company’s two largest shareholders or group of shareholders in terms of ...

TG4050: Promising Phase I data to be presented at SITC 2024 providing clinical proof of principle in adjuvant head and neck cancer setting Financial visibility confirmed into Q4 2025 Strasbourg, ...

At Pack Expo US 2024, ACG Inspection will be debuting its groundbreaking Life Sciences Cloud - a complete end-to-end analytical and traceability solution which aims to deliver production quality, ...

Institutional Investment of £600,000Hemogenyx Pharmaceuticals Secures £0.6m for Phase I Clinical Trials LONDON, UNITED KINGDOM / ACCESSWIRE / November 11, 2024 / Hemogenyx Pharmaceuticals plc ...

ENRICHED CTCS AND CTDNA PROVIDES COMPLEMENTARY INFORMATION IN NSCLC PATIENTS TREATED WITH ASTRAZENECA'S OSIMERTINIBThe addition of CTC-DNA analysis to clinical trials could identify patients ...

The global continuous peripheral nerve block catheter market is poised for significant growth, with revenues expected to rise from USD 585.6 million in 2023 to USD 1,058.6 million by 2033, ...